All Type of News
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, experts claim.
“These clinical trials benefit Ko...
AstraZeneca Korea to launch ‘More Life’ campaign
AstraZeneca Korea said Monday it will launch a fund-raising campaign called ‘More Life’ through a talk show program to support, educate, and inspire those affected by acute coronary syndromes (ACS)
The company has ...
KFDA to take on larger role
The Korea Food and Drug Administration (KFDA) is likely to play a bigger role in improving the nation’s food and drug management as the parliament passed the pending government reorganization bill on Sunday.
The ru...
Drug makers seeking new growth engines
Local drug makers are scrambling to find new growth engines against a deteriorating business environment.
In their regular shareholders meetings on Friday, Korean drug makers vowed to spur efforts to go global and ...
Will pharmaceutical firms survive global giants’ onslaught?
Korean pharmaceutical companies are feeling pressure from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs, they lack competitiveness to take on global players, according...
Ildong’s exclusive distribution of LGLS’s Factive in Korea
LG Life Sciences (LGLS) and Ildong Pharmaceutical announced Friday they have concluded an agreement that Ildong will exclusively distribute Factive (gemifloxacin), a synthetic broad-spectrum antibacterial agent for or...
Korea‘s health insurance outlays for pharmacies down 2.5% in 2012
Korea's health insurance outlays for pharmacies plunged 2.5 percent on-year to 11.79 trillion won in 2012, due to the government’s forced price cut for drugs last April, a state-run agency report said recently.
The...
Government to revamp health insurance system
The nation’s health insurance will not be sustainable if nothing is done to improve its finances. Losses are destined to snowball. As the losses are covered by government subsidies, they will put an enormous strain on...
National health insurance to cover new rheumatism drug
The Ministry of Health and Welfare said Thursday that Janssen Korea’s rheumatism medication Simponi (golimumab) will be covered by national health insurance through the public hearing.
Simponi, the first once-month...
M&As to sweep drug wholesaling industry
Fierce competition and falling profit margins in the pharmaceutical wholesaling industry is making it harder for wholesalers to do business.
Analysts expect a large number of mergers and acquisitions (M&A) to take ...
